TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT
Conditions: Hematopoietic Malignancy; Relapse/Recurrence; Hematopoietic Stem Cell Transplantation Interventions: Procedure: Umbilical Cord Blood Transplantation Sponsors: The First Affiliated Hospital of Soochow University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
Umbilical Cord Mesenchymal Stem Cells for the Repair of Large Area Burn Wounds
Conditions: Large Area Burns Interventions: Procedure: Stem cell preparation combined with Reticular skin; Procedure: Stem cell preparation combined with MEEK skin; Procedure: Stem cell preparation combined with split-thickness skin; Procedure: autologous skin grafting Sponsors: ShiCang Yu Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2023 Category: Research Source Type: clinical trials
Impact of Yoga and Gentle Massage Practices on Symptom Management in Patients Undergoing HSCT
Conditions: Hematopoietic Stem Cell Transplantation; Bone Marrow Transplantation Interventions: Behavioral: yoga or gentle massage plus standard treatment for HSCT Sponsors: Hospital Israelita Albert Einstein Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials
Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.
Conditions: Glioblastoma Interventions: Diagnostic Test: 18F-GE-180 PET; Diagnostic Test: Advanced MRI; Other: Collection of hematopoietic stem cells; Other: Blood withdrawal; Other: Collection of Cancer Stem Cells Sponsors: Istituto Clinico Humanitas; Mediolanum Cardio Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
Study of Human Bone Marrow Mesenchymal Stem Cells in aPAP
Conditions: Autoimmune Pulmonary Alveolar Proteinosis Interventions: Drug: human Bone Marrow Mesenchymal Stem Cell (hBMMSC) Sponsors: Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.; The First Affiliated Hospital of Guangzhou Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2023 Category: Research Source Type: clinical trials
Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
Conditions: Multiple Myeloma Interventions: Drug: Iberdomide; Drug: Daratumumab/rHuPH20 Co-formulation Sponsors: Barbara Ann Karmanos Cancer Institute; Bristol-Myers Squibb; Janssen Pharmaceuticals; Multiple Myeloma Research Consortium Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials
Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy
Conditions: Thrombotic Microangiopathies; Hematopoietic Stem Cell Transplantation Sponsors: Institute of Hematology& Blood Diseases Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials
Qualitative Study on Factors Impeding Physical Activity During the Post-discharge Period After Hematopoietic Stem Cell Transplantation in Children
Conditions: Physical Activities Interventions: Other: interview Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials
A Prospective Approach for the Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health Clinical Center (CC) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health Clinical Center (CC) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
Imaging of Chemotherapy-induced Morphological and Functional Lung Changes in Childhood ALL and HD
Conditions: Acute Lymphoblastic Leukemia; Hodgkin Disease; Allogeneic Stem Cell Transplantation Interventions: Diagnostic Test: Low-field magnetic resonance imaging; Diagnostic Test: Cardiopulmonary testing; Diagnostic Test: Pulmonary testing; Diagnostic Test: Blood sample Sponsors: University of Erlangen-N ürnberg Medical School Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate Mesenchymal Stem Cell Product StromaForte's Effect on Cardiovascular Events
Conditions: Cardiovascular Diseases Interventions: Biological: Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte) Sponsors: Cellcolabs Clinical LTD. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
Psychological Impact of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation on Donors
Conditions: Haplo-identical Transplantation; Transplantation Interventions: Other: Evaluate the evolution of the psychic state of the donors (ascendants and descendants), by means of questionnaires, within the framework of haplo-identical allograft. Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
Study on the Safety and Tolerance of Mesenchymal Stem Cells Mediated by Arthroscopy in Patients With Osteoarthritis
Conditions: Osteoarthritis, Knee Interventions: Biological: Human Umbilical Mesenchymal Stem Cells Sponsors: First Affiliated Hospital of Wannan Medical College Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor
Conditions: GVHD Interventions: Drug: Grafalon; Drug: Thymoglobulin Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
